EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:219592 - Kleboxymycin
| Formula | C12H14N2O3 |
| Net Charge | 0 |
| Average Mass | 234.255 |
| Monoisotopic Mass | 234.10044 |
| SMILES | O=C1c2cccc(O)c2N[C@@H](O)[C@@H]2CCCN12 |
| InChI | InChI=1S/C12H14N2O3/c15-9-5-1-3-7-10(9)13-11(16)8-4-2-6-14(8)12(7)17/h1,3,5,8,11,13,15-16H,2,4,6H2/t8-,11-/m0/s1 |
| InChIKey | QEILHZZUMSPTRX-KWQFWETISA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Klebsiella oxytoca (ncbitaxon:571) | - | PubMed (28972161) |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| Kleboxymycin (CHEBI:219592) is a benzodiazepine (CHEBI:22720) |
| IUPAC Name |
|---|
| (6S,6aS)-4,6-dihydroxy-5,6,6a,7,8,9-hexahydropyrrolo[2,1-c][1,4]benzodiazepin-11-one |